Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 3Lymphoid 2Breast 2Thoracic 1Other 1

Conditions

Cardiovascular Diseases 2Breast Neoplasms 2Metabolic Syndrome 1Cardiotoxicity 1

Interventions

Cyclophosphamide 423Trastuzumab 414Paclitaxel 375Docetaxel 314Capecitabine 265Letrozole 262Carboplatin 257Doxorubicin 213Tamoxifen 184Fulvestrant 176Epirubicin 176Radiotherapy 171Anastrozole 164pembrolizumab 152pertuzumab 147Surveys and Questionnaires 145Exercise 142exemestane 128Vinorelbine 127palbociclib 124Bevacizumab 123Magnetic Resonance Spectroscopy 120Blood Specimen Collection 120Drug Therapy 106Albumin-Bound Paclitaxel 105Gemcitabine 99130-nm albumin-bound paclitaxel 98pyrotinib 92eribulin 90Biopsy 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Blood Pressure × Breast × Clear all
NCT04568161 2025-04-03

Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses

University of Sao Paulo General Hospital

Phase NA Completed
15 enrolled
Breast

Breast Neoplasms, Cardiovascular Diseases, Cardiotoxicity

NCT02652975 2019-10-09

ABCDE

University of Aarhus

Phase NA Completed
76 enrolled
Breast

Breast Neoplasms, Cardiovascular Diseases, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡